UMH Properties declares quarterly dividends for shareholders
UMH Properties, Inc. declares quarterly dividends on common and preferred stock, highlighting financial stability in the real estate investment trust sector.
CNS Pharmaceuticals amends equity plan, elects new directors
CNS Pharmaceuticals updates its equity plan and elects new directors at the annual meeting, signaling ongoing growth in the pharmaceutical sector.
Cerenome updates corporate presentation for investors
Cerenome, Inc. updates its corporate presentation, enhancing investor relations and reflecting industry trends in transparency and communication.
Nova Minerals announces investor update webinar for October
Nova Minerals Corp has scheduled an investor update webinar, emphasizing transparency and engagement with stakeholders in the gold and silver ores sector.
Seritage Growth Properties COO Eric Dinenberg Departs Company
Seritage Growth Properties announces COO Eric Dinenberg's departure effective September 30, 2026, amid strategic shifts in the real estate sector.
United States Antimony Corp secures CEO employment agreement
United States Antimony Corp has signed a new employment agreement with CEO Gary C. Evans, ensuring leadership stability for the company.
Lafayette Square USA declares $0.28 dividend per share
Lafayette Square USA, Inc. announces a $0.28 dividend per share, reflecting a 7.7% annualized yield, signaling strong shareholder value.
Audax Private Credit Fund Declares $0.43 Distribution
Audax Private Credit Fund, LLC declares a $0.43 per share distribution, payable on October 14, 2026, reflecting strong financial health.
BANK 2017-BNK8 appoints new special servicer for mortgage loan
BANK 2017-BNK8 has appointed Torchlight Loan Services as the new special servicer for its Colorado Center mortgage loan, impacting the asset-backed securities industry.
Silexion Therapeutics boosts authorized share capital by 500M
Silexion Therapeutics Corp increases authorized share capital by 500 million shares, enhancing its financial flexibility and growth potential.
Mirum Pharmaceuticals Reports Positive Results for ATEBRIOZ
Mirum Pharmaceuticals shares positive results from the PROGRESS study for ATEBRIOZ in pediatric patients with fibrodysplasia ossificans progressiva.
Cumberland Pharmaceuticals to Submit New Drug Application for Ifetroban
Cumberland Pharmaceuticals plans to submit a New Drug Application for ifetroban, targeting cardiomyopathy in Duchenne muscular dystrophy patients.
CV Sciences settles arbitration with former legal counsel
CV Sciences, Inc. settles arbitration with former legal counsel for $500,000, enhancing its financial position and focusing on core operations.
GrafTech updates costs for Mexico facility closure
GrafTech International Ltd. revises cost estimates for closing its Monterrey facility, signaling a strategic operational shift.
HPS Corporate Lending Fund Declares New Share Distributions
HPS Corporate Lending Fund announces regular and variable supplemental distributions for its common shares, impacting shareholder returns and industry strategies.
Seres Therapeutics CFO Marella Thorell Resigns, Transition Ahead
Marella Thorell resigns as CFO of Seres Therapeutics, effective November 15, 2026, as the company prepares for a leadership transition.
Earth Science Tech CFO Resignation Sparks Leadership Change
Earth Science Tech, Inc. announces CFO Ernesto L. Flores' resignation, with CEO Giorgio R. Saumat stepping in as interim CFO. Leadership transition impacts company strategy.
Gladstone Commercial Corp Announces Board Resignation, New Director
Gladstone Commercial Corp's Board of Directors sees a leadership change as Walter H. Wilkinson Jr. resigns, with George Stelljes appointed as Lead Independent Director.
Gladstone Land Corp appoints new Lead Independent Director
Gladstone Land Corp announces Walter H. Wilkinson Jr.'s resignation and George Stelljes' appointment as Lead Independent Director, marking a leadership transition.
Gladstone Capital Corp announces board leadership change
Gladstone Capital Corp announces the resignation of Walter H. Wilkinson Jr. from its Board and the appointment of George Stelljes as Lead Independent Director.